Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Pleural Effusion, Malignant × Verteporfin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pleural Effusion, Malignant 1 Pinealoma 1 Optic Nerve Glioma 1 Oligodendroglioma 1 Neuroectodermal Tumors, Primitive 1 Neoplasms, Neuroepithelial 1 Neoplasm Metastasis 1 Meningioma 1 Medulloblastoma 1 Gliosarcoma 1 Glioma, Subependymal 1 Glioblastoma 1 Familial ependymoma 1 Ependymoma 1 Craniopharyngioma 1 Choroid Plexus Neoplasms 1 Central Nervous System Neoplasms 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Trastuzumab 2 Carboplatin 2 Bevacizumab 2 tocilizumab 1 tipifarnib 1 romidepsin 1 lipoplatin 1 aldesleukin 1 Verteporfin 1 Valacyclovir 1 Tyrosine Kinase Inhibitors 1 Sorafenib 1 SPI-77, liposomal 1 Photochemotherapy 1 Pharmaceutical Preparations 1 Paclitaxel 1 LMB-100 1 Interleukin-2 1 Interleukin-12 Subunit p35 1 Interleukin-12 1 Immunotherapy, Adoptive 1 Gemcitabine 1 Erlotinib Hydrochloride 1 Docetaxel 1 Decitabine 1 Dasatinib 1 Cytoreduction Surgical Procedures 1 Bortezomib 1 Afatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02702700 2019-03-20

PDT-lipo

Centre Hospitalier Universitaire Vaudois

Phase 1 Terminated

Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡